Correction to: Targeted Inactivation of Rin3 Increases Trabecular Bone Mass by Reducing Bone Resorption and Favouring Bone Formation (Calcified Tissue International, (2021), 109, 1, (92-102), 10.1007/s00223-021-00827-2)

Mahéva Vallet, Antonia Sophocleous, Anna E. Törnqvist, Asim Azfer, Rob van’t Hof, Omar Me Albagha, Stuart H. Ralston*

*Corresponding author for this work

Research output: Contribution to journalComment/debate

Abstract

The original version of this article unfortunately contained a mistake in Funding section. The correct Funding section is given below. Funding This publication is part of a project that has received funding from the European Research Council (ERC) in the form of an advanced investigator award to SHR under the European Union’s Horizon 2020 research and innovation programme (Grant Agreement No. 787270). The publication was also supported in part by a Grant to OMEA from the European Research Council (311723-GENEPAD) and a Grant to SHR from Arthritis Research UK (19799).

Original languageEnglish
Pages (from-to)103
Number of pages1
JournalCalcified Tissue International
Volume109
Issue number1
DOIs
Publication statusPublished - Jul 2021

Fingerprint

Dive into the research topics of 'Correction to: Targeted Inactivation of Rin3 Increases Trabecular Bone Mass by Reducing Bone Resorption and Favouring Bone Formation (Calcified Tissue International, (2021), 109, 1, (92-102), 10.1007/s00223-021-00827-2)'. Together they form a unique fingerprint.

Cite this